Moneycontrol
HomeNewsBusinessStartupMC ExpertEye | Is there a bubble in the making in India’s online learning space? 

MC ExpertEye | Is there a bubble in the making in India’s online learning space? 

Edtech startups have scaled new heights in 2020, with the coronavirus outbreak accelerating the adoption of technology. Will it be a boom or a bust in the new year? Read on

December 18, 2020 / 20:37 IST
Story continues below Advertisement
Representative image

Note to Readers: MC ExpertEye is a weekly series of articles that will dive deep into an important topic by seeking answers from experts.

The coronavirus outbreak and lockdown saw a mushrooming of startups in the education technology (edtech) space that rushed to fill in the gap as schools and colleges shuttered across the country and students were forced to stay home.

Story continues below Advertisement

Not just the unicorns but even smaller companies have managed to attract investors keen on making the most of the opportunity. But is the sector worth the excitement and the bucks? Does it have in it to survive when the outbreak ebbs and people, especially students, can move about freely?

We asked some experts on what they make of the country’s bustling edtech scenario and the challenges it faces. Here is what they have to say:

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show